Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis

Atherosclerosis

Volumn 238, Issue 1, 2015, Pages 17-21

  Potekhina, Alexandra V ^a   Pylaeva, Ekaterina ^a   Provatorov, Sergey ^a   Ruleva, Natalya ^a   Masenko, Valery ^a   Noeva, Elena ^a   Krasnikova, Tatiana ^a   Arefieva, Tatiana ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Coronary artery disease; Regulatory T cells; T helpers 17

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY STENTING; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; REGULATORY T LYMPHOCYTE; STABLE ANGINA PECTORIS; TH1 CELL; TH17 CELL; ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; CYTOLOGY; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84911479006     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.088     Document Type: Article

References (22)

1. Gao Q., Jiang Y., Ma T., et al. Acritical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J.Immunol. 2010, 185:5820-5827.
2. Eid R.E., Rao D.A., Zhou J., et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
3. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 2005, 6:338-344.
4. Pastrana J.L., Sha X., Virtue A., et al. Regulatory T cells and atherosclerosis. J.Clin. Exp. Cardiol. 2012, 8(Suppl.12):2.
5. Takaki H., Ichiyama K., Koga K., Chinen T., Takaesu G., Sugiyama Y., et al. STAT6 Inhibits TGF-_1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J.Biol. Chem. 2008, 283:14955-14962.
6. Roncarolo M.G., Gregori S., Battaglia M., et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
7. Chistiakov D.A., Sobenin I.A., Orekhov A.N. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response. Immunol. Lett. 2013, 151:10-22.
8. Mor A., Luboshits G., Planer D., et al. Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 2006, 27:2530-2537.
9. Sardella G., De Luca L., Francavilla V., et al. Frequency of naturally-occurring regulatory T cells is reduced in patients with ST-segment elevation myocardial infarction. Thromb. Res. 2007, 120:631-634.
10. Han S.F., Liu P., Zhang W., et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin. Immunol. 2007, 124:90-97.
11. Cheng X., Yu X., Ding Y.J., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 2008, 127(1):89-97.
12. Cirillo P., Golino P., Piscione F., et al. Transcoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene?. Int. J. Cardiol. 2011, 153:215-216.
13. Jia L., Zhu L., Wang J.Z., et al. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis 2013, 228:346-352.
14. Li Q., Wang Y., Chen K., et al. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome. Biochem. Biophys. Res. Commun. 2010, 394(3):836-842.
15. Ammirati E., Cianflone D., Banfi M., et al. Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010 Sep, 30(9):1832-1841.
16. Q1 Li, Wang Y., Wang Y., et al. Treg/Th17 ratio acts as a novel indicator for acute coronary syndrome. Cell. Biochem. Biophys. 2014, 10.1007/s12013-014-9993-5.
17. L1 Zhang, Wang T., Wang X.Q., et al. Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome. PLoS One 2013, 8(12). e71466.
18. Austen W.G., Edwards J.E., Frye R.L., et al. Areporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc committee for grading of coronary artery disease, council on cardiovascular surgery american heart association. Circulation 1975, 51:5-40.
19. Gensini G.G. Amore meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 1983, 51:606.
20. Wigren M., Nilsson J., Kolbus D. Lymphocytes in atherosclerosis. Clin. Chim. Acta 2012, 413:1562-1568.
21. Wigren M., Björkbacka H., Andersson L., et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2000-2004.
22. George J., Schwartzenberg S., Medvedovsky D., et al. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 2012, 222(2):519-523.